Two Sigma Investments »

Theriva Biologics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Theriva Biologics (TOVX) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Theriva Biologics

Tip: Access up to 7 years of quarterly data

All positions including Theriva Biologics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theriva Biologics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $25k 62k 0.41
2024-09-30 $19k 14k 1.38

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Theriva Biologics

Ikarian Capital
Two Sigma Investments
Virtu Financial
Jane Street
Boothbay Fund Management
XTX Topco
Geode Capital Management
Two Sigma Advisers
UBS Group
Vanguard Group
Hrt Financial
BlackRock
Advisor Group Holdings
Clear Street
SBI Securities

View all funds holding Theriva Biologics